Please login to the form below

BI

This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s IL-36-targeting drug tackles rare form of psoriasis

Jan Poth. For Boehringer, the successful study in GPP bodes well for BI 655130’s potential in other immune diseases, including more common indications including inflammatory bowel disease. ... Trials of BI 655130 are also underway in palmoplantar

Latest news

AbbVie enters BCMA race with Teneobio deal

The selected anti-CD3 antibodies from TeneoSeek can be incorporated in bi- or multi-specific antibodies to target and destroy tumour cells.
Optimum expands comms offering to Switzerland

Leti holds an MA in Communication and Public Relations from the University of Bucharest and an MSc in Business Strategy from the Norwegian School of Management BI.
Roche builds on Immunocore ImmTAC deal

If the candidate makes it through to commercialisation, it could pave the way for the next-generation of bi-specific biological drugs, potentially disrupting the $100bn monoclonal antibody drug market.
GSK’s says depot HIV injection works over three years

study will try to repeat that finding with bi-monthly dosing.
Boehringer bolts on another immuno-oncology company

Acquires ViraTherapeutics in a €210m takeover deal

More from news
Approximately 4 fully matching, plus 87 partially matching documents found.

Latest Intelligence

The ‘Million Hour Challenge’

Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our
Is it time we stopped talking about adherence?

attractive and valuable bi-product.
Deal Watch September 2016

Boehringer Ingelheim granted Amgen worldwide rights to BI 836909, a bispecific T cell engager designed to treat multiple myeloma. ... Under the agreement, Daiichi Sankyo will acquire a licence to Zymeworks' platforms to develop a bi-specific antibody
The human perspective

But you can deal with the other three factors. This is where Boehringer has a key strength because there is a very, very strong culture, which is built on our BI
Deal Watch April 2016

1, 200. ZymeWorks (US). GSK (UK). License and option. Preclinical bi-specific antibodies based on Azymetric platform for treatment of solid tumours.

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

EphMRA Annual Conference 2018

In this paper, Ursula and Angela will show how they worked together on an initiative which would challenge the BI team’s comfort levels and capabilities, but ultimately elevate customer insights
Box Bear Ltd

A boutique agency punching above its weight. Prefered suppliers of GSK, Roche, Shire and BI to name a few, working directly or with partners to deliver animation, video, webinars, AR and
Frontera Group

Gold - Caphosol sales aid - Sales aid. Gold - BI interactive video - Interactive communications.
Infographic: HIV Market Snapshot

Therapy Watch HIV patient data is collected bi-monthly from a panel of 150 physicians across the main 5 EU markets and 100 physicians in the US.
Delivering successful international business intelligence

He also discusses the approach of configuring a Pharma-specific BI Platform and SaaS solutions as well as touching on hosting choices. .